Tag Archives: Generics

Clamour against United Kingdom’s free-trade negotiator

Posted on March 20, 2023 by donttradeourlivesaway

Groups from India and nearly 40 countries express concern about a leaked chapter from the proposed FTA that they say appears to represent ‘a wish list’ of the pharmaceutical industry. Source: The Telegraph, New Delhi, 20 Mar 2023 Over 200 … Continue reading →

Posted in Access to Medecines, Drug prices, Drugs, FTA, Generics, Transparency, UK- INDIA Free Trade Agreement | Tagged , , , , , , | Leave a comment

India, EU conclude another round of talks for proposed trade agreement

Posted on March 20, 2023 by donttradeourlivesaway

Source: The Economic Times, 19th Mar 2023 India and the European Union (EU) on Saturday concluded the fourth round of talks for a comprehensive free trade agreement in Brussels, a move aimed at further strengthening economic ties between the two sides. The next round of the … Continue reading →

Posted in Access to Medecines, EU-India FTA, FTA | Tagged , , , , , | Leave a comment

Next round of India, UK talks for free trade agreement to be held in March 

Posted on March 20, 2023 by donttradeourlivesaway

Source: Economic Times, 15 Feb 2023 Synopsis After the eight round of talks in March, it could be assessed that how many more rounds would happen and how much more time the talks would take to conclude. The next round … Continue reading →

Posted in FTA, UK- INDIA Free Trade Agreement | Tagged , , , , | Leave a comment

Pfizer’s Covid pill Paxlovid gets WHO’s approval. All you need to know 

Posted on April 22, 2022 by donttradeourlivesaway

Coronavirus disease (COVID-19) treatment pill Paxlovid  (REUTERS) The WHO recommended Paxlovid over remdesivir, as well as over Merck’s molnupiravir pill and monoclonal antibodies. Source: Mint The World Health Organization(WHO) said that it “strongly recommended” Pfizer’s Covid-19 antiviral pill Paxlovid for patients … Continue reading →

Posted in Access to Medicins, COVID-19, Drugs, Generics, Vaccines | Tagged , , , | Leave a comment

Cutting Edge: After Covid, can genome sequencing help identify gene responsible for drug-resistant TB?

Posted on April 20, 2022 by donttradeourlivesaway

Tuberculosis is the leading infectious disease killer in the world and was only recently overtaken by Covid-19. Scientists are keen on exploring whole genome sequencing (WGS) for TB investigation. Source: Indian Express In the past two years, genome sequencing enabled … Continue reading →

Posted in COVID-19, Diseases/Therapies, Drugs, Generics, Tuberculosis (TB) | Tagged , | Leave a comment

Pandemic puts a global spotlight on IP, as countries step-up efforts to be heard

Posted on February 21, 2022 by donttradeourlivesaway

Source: The Hindu Business Line Experts call for more from India, a key voice in the past Last Friday, the African Union marked a milestone as technology to make mRNA vaccines now prepares to roll-out from the world’s first mRNA … Continue reading →

Posted in Antibiotics, COVID-19, Diseases/Therapies, Organizations, Right to Health, Vaccines, WHO | Tagged , , | Leave a comment

Cipla to launch oral anti-viral covid drug Molnupiravir in India 

Posted on December 30, 2021 by donttradeourlivesaway

Source:Mint Cipla Limited on Tuesday announced that the drug maker has been granted Emergency Use Authorisation (EUA) permission by the Drug Controller General of India (DCGI) for the launch of Molnupiravir in the country. Cipla plans to launch Molnupiravir under the brand … Continue reading →

Posted in COVID-19, Diseases/Therapies, Drugs | Tagged , , | Leave a comment

Shortage of key TB drug stress patients; activists urge govt to issue compulsory license

Posted on October 19, 2021 by donttradeourlivesaway

Source: TimeOfIndia MUMBAI: Stockouts are being reported across the country of a key patented drug, Delaminid, used in drug-resistant tuberculosis (DR-TB), hampering the government’s goal of TB elimination and causing hardship to patients. Much worse, the procurement of the drug … Continue reading →

Posted in Access to Medecines, Access to Medicins, Diseases/Therapies, Generics, Tuberculosis (TB) | Tagged , , , , , | Leave a comment

India’s antimicrobial resistance and how to solve this problem

Posted on October 19, 2021 by donttradeourlivesaway

Powerful medications are slowly becoming ineffective for many Indians due to misuse of antibiotics Source: FreePressJournal A recent ICMR report has left healthcare providers, patients, and infection control experts worried about the rising Antimicrobial Resistance in India. The report says … Continue reading →

Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, India, Quality, Vaccines | Tagged , , , , , | Leave a comment

AMR mitigation must top pharma industry’s agenda

Posted on October 19, 2021 by donttradeourlivesaway

To deal with this threat, the pharma sector must adopt environmentally sustainable production and supply chain measures. Source: TheHinduBusinessLine The economic and social consequences of the Covid-19 pandemic have reiterated the destructive capacity of untreatable infectious diseases. While we actively … Continue reading →

Posted in Access to Medicins, Antibiotics, COVID-19, Diseases/Therapies, Drugs, Generics, Right to Health, Vaccines | Tagged , , , , , | Leave a comment